Multistate Epidemiology of Histoplasmosis, United States, 2011–20141
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Histoplasmosis is one of the most common mycoses endemic to the United States, but it was reportable in only 10 states during 2016, when a national case definition was approved.To better characterize the epidemiologic features of histoplasmosis, we analyzed deidentified surveillance data for 2011-2014 from the following 12 states: Alabama, Arkansas, Delaware, Illinois, Indiana, Kentucky, Michigan, Minnesota, Mississippi, Nebraska, Pennsylvania, and Wisconsin.We examined epidemiologic and laboratory features and calculated state-specific annual and county-specific mean annual incidence rates.A total of 3,409 cases were reported.Median patient age was 49 (interquartile range 33-61) years, 2,079 (61%) patients were male, 1,273 (57%) patients were hospitalized, and 76 (7%) patients died.Incidence rates varied markedly between and within states.The high hospitalization rate suggests that histoplasmosis surveillance underestimates the true number of cases.Improved surveillance standardization and surveillance by additional states would provide more comprehensive knowledge of histoplasmosis in the United States. H istoplasmosis is an infection caused by the soil-dwellingthermally dimorphic fungus Histoplasma capsulatum (1).Infection typically results from inhalation of aerosolized spores.Only 1% of sporadic infections are estimated to be symptomatic, although attack rates during outbreaks have been as high as 50%-100%, possibly from high-dose exposure (2).Most symptomatic infections involve primary pulmonary disease; however, extrapulmonary and severe disseminated disease can occur, especially in immunosuppressed persons.Histoplasmosis is often described as the most common mycosis endemic to North America (1), although data to support this statement are limited, given a lack of national public health surveillance.Although once thought to be endemic to a relatively narrow geographic area, histoplasmosis has been increasingly detected in many parts of the world (3,4).According to histoplasmin skin test surveys performed in the 1950s and 1960s in the United States, areas surrounding the Ohio and Mississippi River Valleys are recognized as the regions of predominant histoplasmosis endemicity (5).However, locally acquired infections have been described outside these areas, suggesting that the geographic range of Histoplasma in the United States is wider than is often appreciated (6).This incomplete knowledge about geographic areas of risk could deter clinicians from considering histoplasmosis as a cause of illness, leading to misdiagnosis and inappropriate treatment.A key data source for information about the current geographic distribution and epidemiology of histoplasmosis is disease surveillance.As of 2016, histoplasmosis was reportable in 10 states but not notifiable nationally.Reportable diseases are those that healthcare providers and laboratories are required to report to state, territorial, or local public health authorities.Each jurisdiction's regulation or law determines Multistate Epidemiology of Histoplasmosis, United States,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histoplasmosis: a Clinical and Laboratory Update
Kauffman, C. A. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-06 · Cited by 1,200 · cited 1×
“Only 1% of sporadic infections are estimated to be symptomatic, although attack rates during outbreaks have been as high as 50%–100%, possibly from high-dose exposure (2).”
BackgroundClinical and laboratory update on blastomycosis.
Saccente, M., & Woods, G. L. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-09 · Cited by 450
Coccidioidomycosis as a common cause of community-acquired pneumonia
Valdivia, L., Nix, D., Wright, M., Lindberg, E., Fagan, T., Lieberman, D., Stoffer, T., Ampel, N. M., & Galgiani, J. N. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1206.060028 · Cited by 285
Enhanced surveillance of coccidioidomycosis, Arizona, USA, 2007–2008
Tsang, C. A., Anderson, S. M., Imholte, S. B., Erhart, L. M., Chen, S., Park, B. J., Christ, C., Komatsu, K. K., Chiller, T., & Sunenshine, R. H. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1611.100475 · Cited by 140 · cited 1×
“Increased awareness about histoplasmosis among the public, the public health community, and healthcare providers could improve diagnosis, leading to appropriate treatment and better patient outcomes and reducing harm from administering multiple courses of antibacterial drugs ineffective against fungi, as commonly occu…”
BackgroundMycotic Infections Acquired outside Areas of Known Endemicity, United States
Benedict, K., Thompson, G. R., Deresinski, S., & Chiller, T. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2111.141950 · Cited by 89
Self-citationHistoplasmosis-associated hospitalizations in the United States, 2001–2012
Benedict, K., Derado, G., & Mody, R. K. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv219 · Cited by 51
Self-citation
Cited by
Re-drawing the Maps for Endemic Mycoses
Ashraf, N., Kubat, R. C., Poplin, V., Adenis, A. A., Denning, D. W., Wright, L., McCotter, O., Schwartz, I. S., Jackson, B. R., Chiller, T., et al. (2020) · Mycopathologia · doi:10.1007/s11046-020-00431-2 · Cited by 323
Self-citationToda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6808a1 · Cited by 198
“Unlike other pathogenic fungi, such as Coccidioides and Histoplasma species, which are more prevalent in the environment in specific geographic parts of the United States and hence result in varying incidence geographically (38,39), Candida is believed to be commensal in the human host.”
BackgroundSelf-citationSurveillance for Coccidioidomycosis, Histoplasmosis, and Blastomycosis—United States, 2019.
Smith, D. J., Williams, S. L., Endemic Mycoses State Partners Group, Benedict, K. M., Jackson, B. R., Toda, M., Endemic Mycoses State Partners Group, Adame, G., Rothfeldt, L., Cooksey, G. S., et al. (2022) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss7107a1 · Cited by 75
“65–80 20 (21) 0 (0) 49 (17) 14 (13) 3 (21) 5 (11) 2 (10) 41 (18) 50 (23) 12 (18) 5 (31) 8 (33) 209 (19)”
BackgroundInfluentialSelf-citationRace and ethnicity: Risk factors for fungal infections?
Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011025 · Cited by 55
Update on invasive fungal infections in the Middle Eastern and North African region
Osman, M., Al Bikai, A., Rafei, R., Mallat, H., Dabboussi, F., & Hamze, M. (2020) · Brazilian Journal of Microbiology · doi:10.1007/s42770-020-00325-x · Cited by 39
Metadata
- Authors
- Armstrong, P. A., Jackson, B. R., Haselow, D., Fields, V., Ireland, M., Austin, C., Signs, K., Fialkowski, V., Patel, R., Ellis, P., Iwen, P. C., Pedati, C., Gibbons-Burgener, S., Anderson, J., Dobbs, T., Davidson, S., McIntyre, M., Warren, K., Midla, J., Luong, N., & Benedict, K.
- Venue
- Emerging Infectious Diseases
- Published
- 2017-03
- Volume
- 24
- Issue
- 3
- Pages
- 425-431
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2790490979
- Cited by
- 105
- References
- 6
- FWCI
- 5.75
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multistate Epidemiology of Histoplasmosis, United States, 2011–20141. https://app.cochat.ai/papers/10.3201/eid2403.171258
- The paper
- Armstrong, P. A., Jackson, B. R., Haselow, D., Fields, V., Ireland, M., Austin, C., Signs, K., Fialkowski, V., Patel, R., Ellis, P., Iwen, P. C., Pedati, C., Gibbons-Burgener, S., Anderson, J., Dobbs, T., Davidson, S., McIntyre, M., Warren, K., Midla, J., . . . Benedict, K. (2017). Multistate Epidemiology of Histoplasmosis, United States, 2011–20141. Emerging Infectious Diseases. https://doi.org/10.3201/eid2403.171258
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.